- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x MYU: 3,5,6,7-TETRAHYDROXY-2-(3,4-DIHYDROXYPHENYL)-4H-CHROMEN-4-ONE(Non-covalent)
- 56 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 3 residues within 4Å:- Chain A: N.28
- Chain M: R.50, N.51
Ligand excluded by PLIPSO4.3: 6 residues within 4Å:- Chain A: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.4: 5 residues within 4Å:- Chain A: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.5: 4 residues within 4Å:- Chain A: T.255
- Chain I: R.189, R.192, H.230
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: G.35, K.153, S.155
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: R.263
- Ligands: SO4.43
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain B: P.2, K.3, R.4
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain C: N.28
- Chain O: R.50, N.51
Ligand excluded by PLIPSO4.12: 6 residues within 4Å:- Chain C: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.13: 5 residues within 4Å:- Chain C: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain C: T.255
- Chain K: R.189, R.192, H.230
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain C: G.35, K.153, S.155
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain C: R.263
- Ligands: SO4.52
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain D: P.2, K.3, R.4
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain E: N.28
- Chain I: R.50, N.51
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain E: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain E: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain E: T.255
- Chain O: R.189, R.192, H.230
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain E: G.35, K.153, S.155
Ligand excluded by PLIPSO4.25: 2 residues within 4Å:- Chain E: R.263
- Ligands: SO4.70
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain F: P.2, K.3, R.4
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain G: N.28
- Chain K: R.50, N.51
Ligand excluded by PLIPSO4.30: 6 residues within 4Å:- Chain G: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain G: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain G: T.255
- Chain M: R.189, R.192, H.230
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain G: G.35, K.153, S.155
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain G: R.263
- Ligands: SO4.61
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain H: P.2, K.3, R.4
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain E: R.50, N.51
- Chain I: N.28
Ligand excluded by PLIPSO4.39: 6 residues within 4Å:- Chain I: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain I: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain A: R.189, R.192, H.230
- Chain I: T.255
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain I: G.35, K.153, S.155
Ligand excluded by PLIPSO4.43: 2 residues within 4Å:- Chain I: R.263
- Ligands: SO4.7
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain J: P.2, K.3, R.4
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain G: R.50, N.51
- Chain K: N.28
Ligand excluded by PLIPSO4.48: 6 residues within 4Å:- Chain K: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.49: 5 residues within 4Å:- Chain K: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.50: 4 residues within 4Å:- Chain C: R.189, R.192, H.230
- Chain K: T.255
Ligand excluded by PLIPSO4.51: 3 residues within 4Å:- Chain K: G.35, K.153, S.155
Ligand excluded by PLIPSO4.52: 2 residues within 4Å:- Chain K: R.263
- Ligands: SO4.16
Ligand excluded by PLIPSO4.54: 3 residues within 4Å:- Chain L: P.2, K.3, R.4
Ligand excluded by PLIPSO4.56: 3 residues within 4Å:- Chain A: R.50, N.51
- Chain M: N.28
Ligand excluded by PLIPSO4.57: 6 residues within 4Å:- Chain M: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.58: 5 residues within 4Å:- Chain M: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.59: 4 residues within 4Å:- Chain G: R.189, R.192, H.230
- Chain M: T.255
Ligand excluded by PLIPSO4.60: 3 residues within 4Å:- Chain M: G.35, K.153, S.155
Ligand excluded by PLIPSO4.61: 2 residues within 4Å:- Chain M: R.263
- Ligands: SO4.34
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain N: P.2, K.3, R.4
Ligand excluded by PLIPSO4.65: 3 residues within 4Å:- Chain C: R.50, N.51
- Chain O: N.28
Ligand excluded by PLIPSO4.66: 6 residues within 4Å:- Chain O: Q.37, G.38, K.56, L.57, S.58, H.66
Ligand excluded by PLIPSO4.67: 5 residues within 4Å:- Chain O: K.68, R.72, R.150, L.172, R.174
Ligand excluded by PLIPSO4.68: 4 residues within 4Å:- Chain E: R.189, R.192, H.230
- Chain O: T.255
Ligand excluded by PLIPSO4.69: 3 residues within 4Å:- Chain O: G.35, K.153, S.155
Ligand excluded by PLIPSO4.70: 2 residues within 4Å:- Chain O: R.263
- Ligands: SO4.25
Ligand excluded by PLIPSO4.72: 3 residues within 4Å:- Chain P: P.2, K.3, R.4
Ligand excluded by PLIP- 8 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 1 residues within 4Å:- Chain A: R.127
Ligand excluded by PLIPCL.17: 1 residues within 4Å:- Chain C: R.127
Ligand excluded by PLIPCL.26: 1 residues within 4Å:- Chain E: R.127
Ligand excluded by PLIPCL.35: 1 residues within 4Å:- Chain G: R.127
Ligand excluded by PLIPCL.44: 1 residues within 4Å:- Chain I: R.127
Ligand excluded by PLIPCL.53: 1 residues within 4Å:- Chain K: R.127
Ligand excluded by PLIPCL.62: 1 residues within 4Å:- Chain M: R.127
Ligand excluded by PLIPCL.71: 1 residues within 4Å:- Chain O: R.127
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baek, S. et al., Structural and Functional Analysis of the Natural JNK1 Inhibitor Quercetagetin. J.Mol.Biol. (2013)
- Release Date
- 2012-12-05
- Peptides
- Mitogen-activated protein kinase 8: ACEGIKMO
C-Jun-amino-terminal kinase-interacting protein 1: BDFHJLNP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AB
BD
BF
BH
BJ
BL
BN
BP
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x MYU: 3,5,6,7-TETRAHYDROXY-2-(3,4-DIHYDROXYPHENYL)-4H-CHROMEN-4-ONE(Non-covalent)
- 56 x SO4: SULFATE ION(Non-functional Binders)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baek, S. et al., Structural and Functional Analysis of the Natural JNK1 Inhibitor Quercetagetin. J.Mol.Biol. (2013)
- Release Date
- 2012-12-05
- Peptides
- Mitogen-activated protein kinase 8: ACEGIKMO
C-Jun-amino-terminal kinase-interacting protein 1: BDFHJLNP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AB
BD
BF
BH
BJ
BL
BN
BP
B